Acetylcholinesterase Inhibitors May Improve Myelin Integrity

@article{Bartzokis2007AcetylcholinesteraseIM,
  title={Acetylcholinesterase Inhibitors May Improve Myelin Integrity},
  author={G. Bartzokis},
  journal={Biological Psychiatry},
  year={2007},
  volume={62},
  pages={294-301}
}
  • G. Bartzokis
  • Published 2007
  • Psychology, Medicine
  • Biological Psychiatry
Recent clinical trials have revealed that cholinergic treatments are efficacious in a wide spectrum of neuropsychiatric disorders that span the entire human lifespan and include disorders without cholinergic deficits. Furthermore, some clinical and epidemiological data suggest that cholinergic treatments have disease modifying/preventive effects. It is proposed that these observations can be usefully understood in a myelin-centered model of the human brain. The model proposes that the human… Expand
Remyelination: A Potential Therapeutic Strategy for Alzheimer's Disease?
Cholinesterase inhibition: is there evidence for disease-modifying effects?
Neuroglialpharmacology: Myelination as a shared mechanism of action of psychotropic treatments
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Does Myelin Play the Leading Role in AlzheimerâÂÂs Disease Pathology?
Cholinergic signaling in myelination
Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype
Brain tissue modifications induced by cholinergic therapy in Alzheimer's disease
...
1
2
3
4
...

References

SHOWING 1-10 OF 125 REFERENCES
Nicotinic receptors in aging and dementia.
Cholinesterase inhibitors: new roles and therapeutic alternatives.
Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
...
1
2
3
4
5
...